Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Host-Salmonella interaction: human trials.

M M Levine1, C O Tacket, M B Sztein

  • 1Center for Vaccine Development, University of Maryland School of Medicine, 685 W. Baltimore St., Baltimore, MD 21201, USA. mlevine@medicine.umaryland.edu

Microbes and Infection
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Salmonella Typhi Colonization Provokes Extensive Transcriptional Changes Aimed at Evading Host Mucosal Immune Defense During Early Infection of Human Intestinal Tissue.

EBioMedicine·2018
Same author

Free and complexed-secretory immunoglobulin A triggers distinct intestinal epithelial cell responses.

Clinical and experimental immunology·2016
Same author

Immunization with Ty21a live oral typhoid vaccine elicits crossreactive multifunctional CD8+ T-cell responses against Salmonella enterica serovar Typhi, S. Paratyphi A, and S. Paratyphi B in humans.

Mucosal immunology·2015
Same author

Association of HLA alleles with Plasmodium falciparum severity in Malian children.

Tissue antigens·2011
Same author

A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness.

Vaccine·2011
Same author

Antigen-specific IgA B memory cell responses to Shigella antigens elicited in volunteers immunized with live attenuated Shigella flexneri 2a oral vaccine candidates.

Clinical immunology (Orlando, Fla.)·2011
Same journal

The extent of monocytic myeloid suppressor cells induction determines the host immune response during Mycobacterium avium infection.

Microbes and infection·2025
Same journal

Culture-attenuated pathogenic Leptospira lose the ability to survive complement lytic activity due to decreased C4BP uptake.

Microbes and infection·2025
Same journal

Exploring the link between genetically predicted plasma cathepsins and COVID-19: A mendelian randomization study of susceptibility and severity.

Microbes and infection·2025
Same journal

Laboratory parameters and serum tube agglutination test as markers for brucellosis treatment response.

Microbes and infection·2025
Same journal

Corrigendum to "Lactococcus lactis and Bifidobacterium longum attenuate Clostridioides difficile- or Clostridium symbiosum-induced colitis and depression/anxiety-like behavior in male mice" [Microb Infect 27(7) (2025) 105560].

Microbes and infection·2025
Same journal

Disrupted Microbiome-Metabolome networks underlie gut barrier and immune imbalance in severe fever with thrombocytopenia syndrome.

Microbes and infection·2025
See all related articles

Human clinical trials involving Salmonella Typhi challenge studies, vaccine response monitoring, and efficacy trials have improved our understanding of host-pathogen interactions. These studies are crucial for developing effective typhoid fever interventions.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Clinical Research

Background:

  • Salmonella enterica serovar Typhi causes typhoid fever, a significant global health concern.
  • Understanding host-pathogen interactions is key to controlling Salmonella infections.

Purpose of the Study:

  • To elucidate the complex interactions between Salmonella Typhi and human hosts.
  • To highlight the role of various clinical trial designs in this elucidation.

Main Methods:

  • Experimental human challenge studies with Salmonella Typhi.
  • Phase I and II clinical trials monitoring vaccine-induced immune responses.
  • Large-scale controlled field trials assessing vaccine efficacy in natural settings.

Main Results:

Related Experiment Videos

  • Clinical trials provide critical data on Salmonella Typhi pathogenesis.
  • Immune response monitoring in early trials informs vaccine development.
  • Field trials demonstrate vaccine effectiveness under real-world conditions.

Conclusions:

  • Human clinical trials are indispensable for understanding Salmonella Typhi-human interactions.
  • Diverse trial methodologies contribute to the development of typhoid fever vaccines and control strategies.